Literature DB >> 11677328

Vaginoscopic hysteroscopy and transvaginal sonography in the evaluation of patients with abnormal uterine bleeding.

M Paschopoulos1, E D Lolis, Y Alamanos, G Koliopoulos, E Paraskevaidis.   

Abstract

STUDY
OBJECTIVE: To compare accuracy of vaginoscopic hysteroscopy, a new method of outpatient hysteroscopy, with that of transvaginal sonography in diagnosing intracavitary pathology in women with abnormal uterine bleeding.
DESIGN: Retrospective comparative study (Canadian Task Force classification II-2).
SETTING: Department of gynecology in a tertiary care university hospital. PATIENTS: Three hundred ninety-seven consecutive patients.
INTERVENTIONS: Vaginoscopic hysteroscopy, transvaginal sonography, and histologic evaluation of endometrium.
MEASUREMENTS AND MAIN RESULTS: Findings at hysteroscopy and sonography were compared with histopathologic results, considered the gold standard diagnosis. Sensitivity, specificity, and positive and negative likelihood ratios were 92%, 95%, 18.4, and 0.08 for vaginoscopic hysteroscopy and 67%, 87%, 5.15, and 0.38 for transvaginal sonography, respectively.
CONCLUSION: Vaginoscopic hysteroscopy is quick and well tolerated, and more accurate in detecting intracavitary uterine pathology than transvaginal sonography. More research is required to determine its place in patients with abnormal uterine bleeding, especially premenopausal women.

Entities:  

Mesh:

Year:  2001        PMID: 11677328     DOI: 10.1016/s1074-3804(05)60612-3

Source DB:  PubMed          Journal:  J Am Assoc Gynecol Laparosc        ISSN: 1074-3804


  2 in total

1.  Digital Management of a Hysteroscopy Surgery Using Parts of the SNOMED Medical Model.

Authors:  Anastasios Kollias; Minas Paschopoulos; Angelos Evangelou; Marios Poulos
Journal:  Open Med Inform J       Date:  2012-05-18

Review 2.  Premenopausal abnormal uterine bleeding and risk of endometrial cancer.

Authors:  M E Pennant; R Mehta; P Moody; G Hackett; A Prentice; S J Sharp; R Lakshman
Journal:  BJOG       Date:  2016-10-20       Impact factor: 6.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.